FlyteHealth
Scott Albrecht currently serves as the Chief Financial Officer at FlyteHealth since February 2025. Prior experience includes positions as VP of Operations & Finance at Getlabs from July 2022 to June 2025, VP of Finance at SWORD Health from August 2020 to January 2022, and Vice President of Finance at MealPal in 2020. Scott also held the role of VP, Strategic Growth & Analytics at ECP-PF Holdings, Inc. from December 2017 to December 2019, focusing on corporate development and strategy. Prior to these roles, Scott was a Managing Director at Barings Alternative Investments from September 2009 to October 2016 and a Senior Consultant at Kaiser Associates from 2006 to 2009. Scott's educational background includes a degree from Middlebury College, completed in 2006, and attendance at The American School in Japan from 1997 to 2002.
This person is not in any teams
This person is not in any offices
FlyteHealth
1 followers
FlyteHealth is a tech-enabled healthcare services organization born of the belief that everyone deserves to live a healthy life. Our efforts to bring the most effective health care to people with obesity, while making it cost-efficient to do so, mean that more people can transform their health for the better—now and for the rest of their lives. We were founded by physicians who were the first to recognize obesity not as a simple issue of willpower, but as a complex disease that requires expert medical treatment. Based on their decades of research and caring for patients, our clinically proven approach combines the latest in personalized medication therapy and behavior coaching that not only helps people lose weight for the long term, but significantly improves related conditions. Our obesity treatment platform, powered by Flyte Intelligence, is built from the largest data set of obesity and chronic disease research available, empowering healthcare providers—our own FlyteHealth clinicians and those of our healthcare partners—to deliver the highest standards of care, consistently. While others are jumping on the GLP-1 bandwagon, we see a better way. One that allows employers and payers to offer the best in obesity care, while keeping costs under control. FlyteHealth clinicians prescribe GLP-1 medications strategically, alongside lower-cost generics, for treatment that’s specific to what our patients’ bodies truly need and delivers better control over health care costs. Obesity care goes well beyond weight loss. FlyteHealth gives patients the power to achieve a lifetime of better health. Whether they are actively losing weight or maintaining a normal BMI, we deliver clinical care and coordinate with care teams to help them manage optimal health for life. At FlyteHealth, we’re committed to making sure nothing stands in the way of someone getting the care they need. Together, we’re a collective force for fighting chronic disease.